All In Biotech

Drug Trial Radar · NCT02617446

The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure

The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure - A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel Group Clinical Study

Last checked: Nov 19, 2026Latest source record: May 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Dec 2015

Primary completion

Aug 14, 2018

Study completion Feb 6, 2019

Sponsor

Lead sponsor
Windtree TherapeuticsIndustry
Sponsor type
Industry
First posted
Dec 1, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the safety, tolerability and efficacy of two different doses of istaroxime, a new agent with lusitropic and inotropic activities that improves the cardiac contraction-relaxation cycle. The 2 doses of istaroxime (0.5 and 1.0 µg/kg/min) will be infused via i. v. for 24 hours in comparison with placebo, in treatment of Chinese and Italian patients with Acute Decompensated Heart Failure.

Conditions

  • Acute Decompensated Heart Failure

Interventions

  • PlaceboDrug

    IV of matching saline solution

  • IstaroximeDrug

    IV infusion of 0.5 µg/kg/min or 1.0 µg/kg/min istaroxime

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in E/Ea RatioTime frame: 24 hours

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Fuwai Hospital Chinese Academy of Medical Sciences

    Beijing, China

  • Beijing Chao Yang Hospital

    Beijing, China

  • The 307th Hospital of Chinese People's Liberation Army

    Beijing, China

  • Lanzhou University No.2 Hospital

    Lanzhou, Gansu, China

  • The First Hospital of Lanzhou University

    Lanzhou, Gansu, China

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China

  • Jiangsu Province People's Hospital

    Nanjing, Jiangsu, China

  • The General Hospital Of Shenyang Military Region

    Shenyang, Liaoning, China

  • The First Affiliated Hospital Of Xi'an Jiaotong University

    Xi'an, Shaanxi, China

  • University and Civil Hospital of Brescia

    Brescia, Italy

  • University of Milano-Bicocca

    Milan, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.